A Wöckel
To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
Herbert S, Schwentner L, Fink V, Bekes I, Leinert E, Lato K, Polasik A, Schochter F, Singer S, Salmen J, Diessner J, Stüber T, Wöckel A, Kreienberg R, Kühn T, Flock F, Felberbaum R, Janni W, Curtaz C, Kiesel M, BRENDA study group. To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?. Breast Cancer Res Treat 2020; 185:677-684.
26.10.2020To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis?
26.10.2020Breast Cancer Res Treat 2020; 185:677-684
Herbert S L, Schwentner L, Fink V, Bekes Inga, Leinert E, Lato K, Polasik A, Schochter F, Singer S, Salmen J, Diessner J, Stüber T, Wöckel A, Kreienberg R, Kühn T, Flock F, Felberbaum R, Janni W, Curtaz C, Kiesel M, BRENDA study group
Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal Permeability
Bekes I, Haunerdinger V, Sauter R, Holzheu I, Janni W, Wöckel A, Wulff C. Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal Permeability. Geburtshilfe Frauenheilkd 2017; 77:73-80.
01.01.2017Slit2/Robo4 Signaling: Potential Role of a VEGF-Antagonist Pathway to Regulate Luteal Permeability
01.01.2017Geburtshilfe Frauenheilkd 2017; 77:73-80
Bekes Inga, Haunerdinger V, Sauter R, Holzheu I, Janni W, Wöckel A, Wulff C